Isovaleric acidemia, also called isovaleric aciduria or isovaleric acid CoA dehydrogenase deficiency, is a rare autosomal recessive metabolic disorder which disrupts or prevents normal metabolism of the branched-chain amino acid leucine. It is a classical type of organic acidemia.
A characteristic feature of isovaleric acidemia is a distinctive odor of sweaty feet. This odor is caused by the buildup of a compound called isovaleric acid in affected individuals.
In about half of cases, the signs and symptoms of this disorder become apparent within a few days after birth and include poor feeding, vomiting, seizures, and lack of energy that can progress to coma. These medical problems are typically severe and can be life-threatening. In the other half of cases, the signs and symptoms of the disorder appear during childhood and may come and go over time. They are often triggered by an infection or by eating an increased amount of protein-rich foods.
The urine of newborns can be screened for isovaleric acidemia using mass spectrometry, allowing for early diagnosis.
Isovaleric acidemia is estimated to affect at least 1 in 250,000 births in the United States.
The disorder has an autosomal recessive inheritance pattern, which means the defective gene is located on an autosome, and two copies of the gene - one from each parent - must be inherited to be affected by the disorder. The parents of a child with an autosomal recessive disorder are carriers of one copy of the defective gene, but are usually not affected by the disorder.
Mutations in both copies of the IVD gene result in isovaleric acidemia.
The enzyme encoded by IVD, isovaleric acid-CoA dehydrogenase plays an essential role in breaking down proteins from the diet. Specifically, the enzyme is responsible for the third step in processing leucine, an essential amino acid. If a mutation in the IVD gene reduces or eliminates the activity of this enzyme, the body is unable to break down leucine properly. As a result, isovaleric acid and related compounds build up to toxic levels, damaging the brain and nervous system.
Wipo Publishes Patent of Carlo Dionisi-Vici, Enrico Bertini, Diego Martinelli, Edison Pharmaceuticals, Guy M. Miller for "Treatment of Methylmalonic Aciduria, Isovaleric Aciduria and Other Organic Acidurias with Tocotrienol Quinones" (Italian, American Inventors)
Jan 15, 2013; GENEVA, Jan. 15 -- Publication No. WO/2013/006737 was published on Jan. 10.Title of the invention: "TREATMENT OF METHYLMALONIC...